Global & Liquid Biopsy market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023 - Asia Pacific Market Research

Global & Liquid Biopsy market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023

Global & Liquid Biopsy market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023

  • Report Description
  • Table of Content APAC
  • Table of Content
  • Request for Sample

Liquid biopsy is a non-invasive process of analyzing non-solid tissues such as blood. Analysis of non-solid tissues helps to diagnose and monitor cancer. Liquid biopsy market in Asia Pacific region is depicted to growth with a CAGR of about 26.3% during the years 2016-2022. The market was valued at $141 million in the year 2015 and is anticipated to grow at $571 million by the year 2022. Surging number of cancer treatments in APAC region has promoted huge growth in the market. Some other factors such as huge investments in cancer based research in Asia Pacific region, benefits of liquid biopsy over surgical biopsy and decreasing rate of cancer mortality due to prevalence of liquid biopsy have also helped to back the market. In Global Liquid biopsy market, North American region is a leading market.  Asia pacific region can be observed as the fastest growing region comparatively.

Rising number of cancer cases can be observed in Asia Pacific region. About 43% of cancer diagnosed in males and 38% of cancer diagnosed in females are in 15 Asian countries that is about 3 times of total cases in US. Total 56% of world population in APAC countries contributes to about 44% of cancer cases and about 51% of deaths due to cancer globally.  Asia has about half the incident rate of cancer as compared to North America. About 152.2 cases are observed on 100,000 persons every year. Developing countries such as India, China, Philippine accounts for major cases of cervical cancers. India contributes to about 27% of global deaths through cervical cancer due to unavailability of screening. Japan contributes about 12% of total cases of cancer in this region. Liquid biopsy has helped to lower the mortality rate in developing countries. As a result of increase in number of cases, liquid biopsy has been readily adopted for cancer treatment in Asia Pacific region.

Timely diagnosis and monitoring of cancer with the increasing adoption of liquid biopsy, has enabled the medical practitioners to efficiently provide treatment and therapies for cancer. Gradual decrease in the cancer mortality rate can be observed in Asia Pacific region. In Korea survival rate in stomach cancer has increase by about 58% in South Korea. Similarly in India, survival rate in colon cancer has increased by 37%. However as compared to other developed countries that have an average survival rate of 50-59%, the survival rate in India is still low. This has projected India as a promising country for the further development of liquid biopsy market.

The liquid biopsy market has been segmented on the basis of type of cancer, by end user, by circulating biomarkers and by products and services. On the basis of type of cancer the market is classified as colorectal cancer, lung cancer, prostate cancer, liver cancer, breast cancer and other types of cancer based liquid biopsies. Lung cancer is the second most common cancer among the males of Asia Pacific region except India, Japan, Mongolia and Taiwan. As a result to it, lung cancer based liquid biopsy is a widespread biopsy technique in this region and majorly contributes to the generation of revenue in the liquid biopsy market. On the basis of end users the liquid biopsy has been further segmented as reference laboratories, academic and research centers, hospitals and physician laboratories, and other end users. Further on the basis of circulating biomarkers the market has been classified as circulating tumor cells, extracellular vesicles, tumor DNA and other biomarkers based liquid biopsy. By products, the market has been classified as reagent based, service and software based liquid biopsy. Asia Pacific Liquid biopsy market has been geographically segmented as China, India, Japan, Korea and Australia. China alone accounts for a 50% of cancer cases in APAC region and is a leading market for Liquid biopsy. India is expected to be the fastest growing market that contributes to approximately 16% of cancer cases in this region presently that is expected to rise at 1.1 million cases by the year 2020.

Some of the major companies dealing in the market of liquid biopsy are Janssen Diagnostics, Qiagen, SRI International, Myriad Genetics, Hansabiomed OU, RainDance Technologies, Datar Genetics Limited, Biocept, Transgenomic, Core Diagnostics, Accuragen, Agena Bioscience, Epigenomics, Clearbridge Biomedics Pte LTD, SelectBio and others. Companies have adopted the strategies like merger, acquisition, product launch, and expansion in order to sustain in the market. Recently on January 2017, Qiagen has enhanced the bioinformatics portfolio by acquiring OmicSoft. This will provide Qiagen with an access to multi omics based data management solution provided by OmicSoft. Software solutions of OmicSoft enables the scientist and researchers to compare their data with publicly available data such as Cancer Genome Atlas and others.

  1. INTRODUCTION
    • EXECUTIVE SUMMARY
    • ESTIMATION METHODOLOGY
  2. MARKET OVERVIEW
    • MARKET DEFINITION AND SCOPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • PORTERS 5 FORCE MODEL
    • KEY MARKET TRENDS
      • PIPELINE ANALYSIS
      • R & D SCENARIO
      • REGULATORY FRAMEWORK
    • PARAMETRIC ANALYSIS
    • KEY MARKET INSIGHTS
      • TOP 3 EMERGING COUNTRIES
      • TOP 3 REVENUE GENERATING SEGMENTS
      • TOP 3 EMERGING SEGMENTS
    • COMPETITIVE INTELLIGENCE
      • MARKET SHARE ANALYSIS
      • TOP WINNING STRATEGIES
      • CASE STUDY: TOP COMPETITIVE MOVES
    • STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
      • INVESTMENT OPPORTUNITIES BY COUNTRIES
      • OPPORTUNITIES IN EMERGING APPLICATIONS
      • INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • SURGING NUMBER OF CANCER TREATMENTS
      • HUGE INVESTMENTS IN CANCER BASED RESEARCH
      • BENEFITS OF LIQUID BIOPSY OVER SURGICAL BIOPSY
      • LIQUID BIOPSY DECREASING CANCER MORTALITY
    • MARKET RESTRAINTS
      • LACK OF SENSITIVITY IN THE CANCER DIAGNOSIS
      • STRINGENT AND COMPLEX REGULATORY PROCESS
    • MARKET OPPORTUNITIES
      • RISE IN ADOPTION OF LIQUID BIOPSY TECHNIQUE BY EMERGING ECONOMIES
      • INCREASING DEMAND OF LIQUID BIOPSY IN DIAGNOSING ACUTE MYOCARDIAL INFARCTION
    • MARKET CHALLENGES
      • LACK OF AWARENESS FOR LIQUID BIOPSY
      • LACK OF SKILLED PERSONNEL’S IN EMERGING COUNTRIES
  1. MARKET SEGMENTATION
    • APAC LIQUID BIOPSY MARKET BY TYPE OF CANCER 2014 -2022 ($ MILLION)
      • APAC LUNG CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC BREAST CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC COLORECTAL CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC PROSTATE CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC LIVER CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC OTHER CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • APAC LIQUID BIOPSY MARKET BY END USERS 2014 -2022 ($ MILLION)
      • APAC LIQUID BIOPSY MARKET BY REFERENCE LABORATORIES 2014 -2022 ($ MILLION)
      • APAC LIQUID BIOPSY MARKET BY HOSPITALS AND PHYSICIAN LABORATORIES 2014 -2022 ($ MILLION)
      • APAC LIQUID BIOPSY MARKET BY ACADEMIC AND RESEARCH CENTERS 2014 -2022 ($ MILLION)
      • APAC LIQUID BIOPSY MARKET BY OTHER END USERS 2014 -2022 ($ MILLION)
    • APAC LIQUID BIOPSY MARKET BY CIRCULATING BIOMARKERS 2014 -2022 ($ MILLION)
      • APAC CIRCULATING TUMOR CELLS LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC EXTRACELLULAR VESICLES LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC CIRCULATING TUMOR DNA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC OTHER BIOMARKERS LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • APAC LIQUID BIOPSY MARKET BY PRODUCTS AND SERVICES 2014 -2022 ($ MILLION)
      • APAC REAGENTS BASED LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • APAC SERVICE AND SOFTWARE BASED LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  1. GEOGRAPHIC ANALYSIS
    • CHINA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • INDIA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • KOREA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • JAPAN LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • AUSTRALIA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • THAILAND LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • REST OF ASIA PACIFIC LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  2. GLOBAL VS APAC MARKET “A COMPARATIVE STUDY”
    • DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • OPPORTUNITY MATRIX
    • US VS APAC MARKET
    • EUROPE VS APAC MARKET
    • ROW VS APAC MARKET
  3. COMPANY PROFILES
    • JANSSEN DIAGNOSTICS
    • QIAGEN
    • SRI INTERNATIONAL
    • MYRIAD GENETICS
    • HANSABIOMED OU
    • RAINDANCE TECHNOLOGIES
    • DATAR GENETICS LIMITED
    • BIOCEPT
    • TRANSGENOMIC
    • CORE DIAGNOSTICS
    • ACCURAGEN
    • AGENA BIOSCIENCE
    • EPIGENOMICS
    • SELECTBIO
    • CLEARBRIDGE BIOMEDICS PTE LTD.

LIST OF TABLES

  1. APAC LIQUID BIOPSY MARKET BY TYPE OF CANCER 2014 -2022 ($ MILLION)
  2. APAC LUNG CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  3. APAC BREAST CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  4. APAC COLORECTAL CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  5. APAC PROSTATE CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  6. APAC LIVER CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  7. APAC OTHER CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  8. APAC LIQUID BIOPSY MARKET BY END USERS 2014 -2022 ($ MILLION)
  9. APAC LIQUID BIOPSY MARKET BY REFERENCE LABORATORIES BY GEOGRAPHY 2014 -2022 ($ MILLION)
  10. APAC LIQUID BIOPSY MARKET BY HOSPITALS AND PHYSICIAN LABORATORIES BY GEOGRAPHY 2014 -2022 ($ MILLION)
  11. APAC LIQUID BIOPSY MARKET BY ACADEMIC AND RESEARCH CENTERS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  12. APAC LIQUID BIOPSY MARKET BY OTHER END USERS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  13. APAC LIQUID BIOPSY MARKET BY CIRCULATING BIOMARKERS 2014 -2022 ($ MILLION)
  14. APAC CIRCULATING TUMOR CELLS LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  15. APAC EXTRACELLULAR VESICLES LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  16. APAC CIRCULATING TUMOR DNA LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  17. APAC OTHER BIOMARKERS LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  18. APAC LIQUID BIOPSY MARKET BY PRODUCTS AND SERVICES 2014 -2022 ($ MILLION)
  19. APAC REAGENTS BASED LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  20. APAC SERVICE AND SOFTWARE BASED LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)

LIST OF FIGURE

  1. APAC LUNG CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  2. APAC BREAST CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  3. APAC COLORECTAL CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  4. APAC PROSTATE CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  5. APAC LIVER CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  6. APAC OTHER CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  7. APAC LIQUID BIOPSY MARKET BY REFERENCE LABORATORIES 2014 -2022 ($ MILLION)
  8. APAC LIQUID BIOPSY MARKET BY HOSPITALS AND PHYSICIAN LABORATORIES 2014 -2022 ($ MILLION)
  9. APAC LIQUID BIOPSY MARKET BY ACADEMIC AND RESEARCH CENTERS 2014 -2022 ($ MILLION)
  10. APAC LIQUID BIOPSY MARKET BY OTHER END USERS 2014 -2022 ($ MILLION)
  11. APAC CIRCULATING TUMOR CELLS LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  12. APAC EXTRACELLULAR VESICLES LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  13. APAC CIRCULATING TUMOR DNA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  14. APAC OTHER BIOMARKERS LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  15. APAC REAGENTS BASED LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  16. APAC SERVICE AND SOFTWARE BASED LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  17. INDIA LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  18. CHINA LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  19. JAPAN LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  20. KOREA LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  21. AUSTRALIA LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  1. INTRODUCTION
    • EXECUTIVE SUMMARY
    • ESTIMATION METHODOLOGY
  2. MARKET OVERVIEW
    • MARKET DEFINITION AND SCOPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • PORTERS 5 FORCE MODEL
    • KEY MARKET TRENDS
      • PIPELINE ANALYSIS
      • R & D SCENARIO
      • REGULATORY FRAMEWORK
    • PARAMETRIC ANALYSIS
    • KEY MARKET INSIGHTS
      • TOP 3 EMERGING COUNTRIES
      • TOP 3 REVENUE GENERATING SEGMENTS
      • TOP 3 EMERGING SEGMENTS
    • COMPETITIVE INTELLIGENCE
      • MARKET SHARE ANALYSIS
      • TOP WINNING STRATEGIES
      • CASE STUDY: TOP COMPETITIVE MOVES
    • STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
      • INVESTMENT OPPORTUNITIES BY COUNTRIES
      • OPPORTUNITIES IN EMERGING APPLICATIONS
      • INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • SURGING NUMBER OF CANCER TREATMENTS GLOBALLY
      • HUGE INVESTMENTS IN CANCER BASED RESEARCH
      • BENEFITS OF LIQUID BIOPSY OVER SURGICAL BIOPSY
      • LIQUID BIOPSY DECREASING CANCER MORTALITY
    • MARKET RESTRAINTS
      • SENSITIVITY ISSUES IN CANCER DIAGNOSIS
      • STRINGENT AND COMPLEX REGULATORY PROCESS
    • MARKET OPPORTUNITIES
      • RISE IN ADOPTION OF LIQUID BIOPSY TECHNIQUE BY EMERGING ECONOMIES
      • INCREASING DEMAND OF LIQUID BIOPSY IN DIAGNOSING ACUTE MYOCARDIAL INFARCTION
    • MARKET CHALLENGES
      • LACK OF AWARENESS FOR LIQUID BIOPSY
      • LACK OF SKILLED PERSONNEL’S IN EMERGING COUNTRIES
  1. MARKET SEGMENTATION
    • GLOBAL LIQUID BIOPSY MARKET BY TYPE OF CANCER 2014 -2022 ($ MILLION)
      • GLOBAL LUNG CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL BREAST CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL COLORECTAL CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL PROSTATE CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL LIVER CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL OTHER CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • GLOBAL LIQUID BIOPSY MARKET BY END USERS 2014 -2022 ($ MILLION)
      • GLOBAL LIQUID BIOPSY MARKET BY REFERENCE LABORATORIES 2014 -2022 ($ MILLION)
      • GLOBAL LIQUID BIOPSY MARKET BY HOSPITALS AND PHYSICIAN LABORATORIES 2014 -2022 ($ MILLION)
      • GLOBAL LIQUID BIOPSY MARKET BY ACADEMIC AND RESEARCH CENTERS 2014 -2022 ($ MILLION)
      • GLOBAL LIQUID BIOPSY MARKET BY OTHER END USERS 2014 -2022 ($ MILLION)
    • GLOBAL LIQUID BIOPSY MARKET BY CIRCULATING BIOMARKERS 2014 -2022 ($ MILLION)
      • GLOBAL CIRCULATING TUMOR CELLS LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL EXTRACELLULAR VESICLES LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL CIRCULATING TUMOR DNA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL OTHER BIOMARKERS LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • GLOBAL LIQUID BIOPSY MARKET BY PRODUCTS AND SERVICES 2014 -2022 ($ MILLION)
      • GLOBAL REAGENTS BASED LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GLOBAL SERVICE AND SOFTWARE BASED LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  1. GEOGRAPHIC ANALYSIS
    • NORTH AMERICA
      • S. LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • CANADA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • EUROPE
      • K. LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • FRANCE LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • GERMANY LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • ITALY LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • REST OF EUROPE LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • ASIA PACIFIC
      • CHINA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • INDIA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • JAPAN LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • AUSTRALIA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • REST OF APAC LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
    • ROW
      • LATIN AMERICA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
      • MIDDLE EAST LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  1. COMPANY PROFILES
    • MDX HEALTH SA
    • JANSSEN DIAGNOSTICS
    • QIAGEN
    • BIO-RAD LABORATORIES INC
    • SRI INTERNATIONAL
    • MYRIAD GENETICS
    • FRAUNHOFER-GESELLSCHAFT
    • HANSABIOMED OU
    • RAINDANCE TECHNOLOGIES
    • DATAR GENETICS LIMITED
    • BIOCEPT
    • ACCURAGEN
    • AGENA BIOSCIENCE
    • HOFFMANN-LA ROCHE AG
    • GUARDANT HEALTH INC

LIST OF TABLES

  1. GLOBAL LIQUID BIOPSY MARKET BY TYPE OF CANCER 2014 -2022 ($ MILLION)
  2. GLOBAL LUNG CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  3. GLOBAL BREAST CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  4. GLOBAL COLORECTAL CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  5. GLOBAL PROSTATE CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  6. GLOBAL LIVER CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  7. GLOBAL OTHER CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  8. GLOBAL LIQUID BIOPSY MARKET BY END USERS 2014 -2022 ($ MILLION)
  9. GLOBAL LIQUID BIOPSY MARKET BY REFERENCE LABORATORIES BY GEOGRAPHY 2014 -2022 ($ MILLION)
  10. GLOBAL LIQUID BIOPSY MARKET BY HOSPITALS AND PHYSICIAN LABORATORIES BY GEOGRAPHY 2014 -2022 ($ MILLION)
  11. GLOBAL LIQUID BIOPSY MARKET BY ACADEMIC AND RESEARCH CENTERS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  12. GLOBAL LIQUID BIOPSY MARKET BY OTHER END USERS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  13. GLOBAL LIQUID BIOPSY MARKET BY CIRCULATING BIOMARKERS 2014 -2022 ($ MILLION)
  14. GLOBAL CIRCULATING TUMOR CELLS LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  15. GLOBAL EXTRACELLULAR VESICLES LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  16. GLOBAL CIRCULATING TUMOR DNA LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  17. GLOBAL OTHER BIOMARKERS LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  18. GLOBAL LIQUID BIOPSY MARKET BY PRODUCTS AND SERVICES 2014 -2022 ($ MILLION)
  19. GLOBAL REAGENTS BASED LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  20. GLOBAL SERVICE AND SOFTWARE BASED LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  21. NORTH AMERICA LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  22. EUROPE LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  23. ASIA PACIFIC LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  24. REST OF THE WORLD LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)

LIST OF FIGURE

  1. GLOBAL LUNG CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  2. GLOBAL BREAST CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  3. GLOBAL COLORECTAL CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  4. GLOBAL PROSTATE CANCER LIQUID BIOPSY MARKET BY GEOGRAPHY 2014 -2022 ($ MILLION)
  5. GLOBAL LIVER CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  6. GLOBAL OTHER CANCER LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  7. GLOBAL LIQUID BIOPSY MARKET BY REFERENCE LABORATORIES 2014 -2022 ($ MILLION)
  8. GLOBAL LIQUID BIOPSY MARKET BY HOSPITALS AND PHYSICIAN LABORATORIES 2014 -2022 ($ MILLION)
  9. GLOBAL LIQUID BIOPSY MARKET BY ACADEMIC AND RESEARCH CENTERS 2014 -2022 ($ MILLION)
  10. GLOBAL LIQUID BIOPSY MARKET BY OTHER END USERS 2014 -2022 ($ MILLION)
  11. GLOBAL CIRCULATING TUMOR CELLS LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  12. GLOBAL EXTRACELLULAR VESICLES LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  13. GLOBAL CIRCULATING TUMOR DNA LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  14. GLOBAL OTHER BIOMARKERS LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  15. GLOBAL REAGENTS BASED LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  16. GLOBAL SERVICE AND SOFTWARE BASED LIQUID BIOPSY MARKET 2014 -2022 ($ MILLION)
  17. NORTH AMERICA LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  18. EUROPE LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  19. ASIA PACIFIC LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)
  20. REST OF THE WORLD LIQUID BIOPSY MARKET 2014-2022 ($ MILLION)

 

 

Name

Email

Phone

Company Name

Country

Report Title